GLP-1 RA medications safe and effective for treating obesity in adults with mental illness
Peer-Reviewed Publication
Updates every hour. Last Updated: 16-Jun-2025 01:09 ET (16-Jun-2025 05:09 GMT/UTC)
*Please mention the European Congress on Obesity (ECO 2025, Malaga, Spain, 11-14) if using this research*
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) can lead to significant weight loss and improve blood sugar control in adults with severe mental illness, as well as having positive effects on mood, well-being, and quality of life in those both with and without mental illness, according to a systematic review of the available evidence being presented at this year’s European Congress on Obesity (ECO) in Malaga, Spain (11-14 May).
A research paper by scientists at Zhejiang University presented.
A research paper by scientists at Imperial College London presented CrystalTac, a vision-based tactile sensor family fabricated via rapid monolithic manufacturing.
Boys born to mothers who have polycystic ovary syndrome (PCOS) or who have higher levels of testosterone during the third trimester are more likely to be less physically active at age 7, according to research presented at the first Joint Congress between the European Society of Paediatric Endocrinology (ESPE) and the European Society of Endocrinology (ESE). Testosterone levels or PCOS in the mothers were not associated with physical activity in girls, but 7-year-old girls whose mothers had higher testosterone levels during pregnancy had lower muscle strength. The findings highlight the important role that maternal testosterone and PCOS may play in future development in boys and girls independently.